|Articles|September 13, 2021
Leveraging the Power of mAb Purification via N-Linked Glycans Using a FcR-IIIA Resin and Its Comparison to Protein A
Author(s)Tosoh Bioscience LLC
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
How Biopharma Navigates the 2026 Economic Shift
2
EC’s High-Dose Aflibercept Approval Highlights Durable Anti-VEGF Retinal Therapy
3
Beyond Transactional: Collaborative Partnerships for Rapid, Flexible Biologics Development
4
Adenovirus Vectors, Cyclodextrins and the Patient Experience: A Deep Dive
5